Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein D is a highly conserved 42 kDa surface lipoprotein present in all strains of *Haemophilus influenzae*, including both encapsulated and nonencapsulated (nontypeable, NTHi) forms. It is located on the outer membrane of the bacterium and plays a significant role in its pathogenicity, particularly in respiratory tract infections such as otitis media and exacerbations of chronic obstructive pulmonary disease (COPD). It acts as a virulence factor by impairing ciliary function, promoting bacterial adhesion and invasion, and possessing glycerophosphodiester phosphodiesterase activity. Due to its high conservation, surface exposure, and role in pathogenesis, protein D has been extensively studied as a vaccine candidate and is used as a carrier protein in conjugate vaccines like Synflorix™.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-typeable Haemophilus influenzae Protein D (None).